|
Preston, K L; Bigelow, G E (2000) Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination. J Pharmacol Exp Ther 295:114-24
|
|
Jones, H E; Bigelow, G E; Preston, K L (1999) Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure. J Pharmacol Exp Ther 289:1350-61
|
|
Preston, K L; Bigelow, G E (1998) Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533-43
|
|
Dykstra, L A; Preston, K L; Bigelow, G E (1997) Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology (Berl) 130:14-27
|
|
Preston, K L; Bigelow, G E (1994) Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure. J Pharmacol Exp Ther 271:48-60
|
|
Preston, K L; Bigelow, G E (1993) Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers. J Pharmacol Exp Ther 264:813-23
|
|
Strain, E C; Preston, K L; Liebson, I A et al. (1993) Precipitated withdrawal by pentazocine in methadone-maintained volunteers. J Pharmacol Exp Ther 267:624-34
|
|
Strain, E C; Preston, K L; Liebson, I A et al. (1992) Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J Pharmacol Exp Ther 261:985-93
|
|
Weinhold, L L; Preston, K L; Farre, M et al. (1992) Buprenorphine alone and in combination with naloxone in non-dependent humans. Drug Alcohol Depend 30:263-74
|
|
Bigelow, G E; Preston, K L (1992) Assessment of buprenorphine in a drug discrimination procedure in humans. NIDA Res Monogr 121:28-37
|
Showing the most recent 10 out of 30 publications
